Literature DB >> 32572707

The role of initial chest X-ray in triaging patients with suspected COVID-19 during the pandemic.

Hyunjoong W Kim1, K M Capaccione2, Gen Li3, Lyndon Luk2, Reginald S Widemon2, Ozair Rahman2, Volkan Beylergil2, Ryan Mitchell2, Belinda M D'Souza2, Jay S Leb2, Shifali Dumeer2, Stuart Bentley-Hibbert2, Michael Liu2, Sachin Jambawalikar2, John H M Austin2, Mary Salvatore2.   

Abstract

PURPOSE: The purpose of our research is to evaluate the usefulness of chest X-ray for triaging patients with suspected COVID-19 infection.
METHODS: IRB approval was obtained to allow a retrospective review of adult patients who presented to the Emergency Department with a complaint of fever, cough, dyspnea or hypoxia and had a chest X-ray between 12 March 2020 and 26 March 2020. The initial chest X-ray was graded on a scale of 0-3 with grade 0 representing no alveolar opacities, grade 1: < 1/3 alveolar opacities of the lung, Grade 2: 1/3 to 2/3 lung with alveolar opacities and grade 3: > 2/3 alveolar opacities of the lung. Past medical history of diabetes and hypertension, initial oxygen saturation, COVID-19 testing results, intubation, and outcome were also collected.
RESULTS: Four hundred ten patient chest X-rays were reviewed. Oxygen saturation and X-ray grade were both significantly associated with the length of stay in hospital, the hazard ratio (HR) of discharge was 1.05 (95% CI [1.01, 1.09], p = 0.017) and 0.61 (95% CI [0.51, 0.73], p < 0.001), respectively. In addition, oxygen saturation and X-ray grade were significant predictors of intubation (odds ratio (OR) of intubation is 0.88 (95% CI [0.81, 0.96], p = 0.004) and 3.69 (95% CI [2.25, 6.07], p < 0.001).
CONCLUSIONS: Initial chest X-ray is a useful tool for triaging those subjects who might have poor outcomes with suspected COVID-19 infection and benefit most from hospitalization.

Entities:  

Keywords:  COVID-19; CXR; Chest; Coronavirus; SARS-CoV-2; X-ray

Mesh:

Year:  2020        PMID: 32572707      PMCID: PMC7306559          DOI: 10.1007/s10140-020-01808-y

Source DB:  PubMed          Journal:  Emerg Radiol        ISSN: 1070-3004


Introduction

COVID-19 is the name of the disease caused by the novel coronavirus (SARS-CoV-2) that originated from Wuhan, China in December 2019 [1]. Since then, there have been numerous cases outside of China, as evidenced by a declaration of “public health emergency of international concern” by the World Health Organization (WHO) on 30 January 2020. The USA has seen a significant increase in positive COVID-19 cases since its first documented positive patient on 20 January 2020 and currently has over 475,000 cases nationwide as of 10 April 2020, with New York City accounting for over 92,000 cases. WHO declared COVID-19 as a pandemic on 11 March 2020. The COVID-19 pandemic is not the first pandemic of the twenty-first century, yet it is the most impactful due to the relative ease of transmission, number of victims, and death rate globally. Alonso-Zaldivar described the ubiquity of the disease with 3 out of 4 US hospitals caring for COVID-19 patients. Many patients are treated as if they are infected because of the uncertainty of available testing procedures [2]. Access to diagnostic PCR testing was initially limited because of a short supply of testing kits; only patients whose treatment would be altered based on the results or those at high risk for a poor clinical outcome were tested [3]. Chest X-rays are ordered for most patients who present to the emergency room with symptoms suggestive of COVID-19 and have been used as a surrogate marker for disease in lieu of adequate PCR testing. The classic appearance on chest X-ray is lower lobe predominant alveolar opacities often with superimposed atelectasis [4]. However, chest radiographs are limited for diagnosis in that they may be normal in early or mild disease [5]. The purpose of the present study is to see if initial chest radiographs in the Emergency Department (ED) of a large New York City hospital located in northern Manhattan could be beneficial in triaging patients with suspected COVID-19 infection.

Methods

IRB approval was obtained to allow a retrospective review of adult patients (age 21 or older) who presented to the ED with a complaint of fever, cough, dyspnea, or hypoxia and had an initial chest radiograph between 12 March 2020 and 26 March 2020. Waiver of informed consent was approved by the institution. Data was stored on Box (Box, Inc., Redwood City, CA, USA), which is a HIPAA-compliant cloud storage system. Initial data set was extracted with M*Modal Catalyst (M*Modal, Pittsburgh, PA, USA), an advanced query software, of ED chest radiographs with clinical indication of “fever,” “cough,” “dyspnea,” and “hypoxia.” These key words were chosen to widely capture patients with suspected COVID-19 symptoms during the initial pandemic when there was shortage of laboratory testing. One thousand two hundred fifty-six patients satisfied these criteria and a random sample of 416 was taken to be analyzed. The patients’ medical records were reviewed and age, gender and initial oxygen saturation were documented. Also, note was made of history of diabetes and hypertension. If performed, the patient’s SARS-CoV-2 status was recorded along with patient outcome (discharged from ED, admission, or death). The chest radiographs were reviewed by an experienced thoracic radiologist with over 20 years of experience and graded on a scale of 0–3 with grade 0 representing no alveolar opacities, grade 1: < 1/3 alveolar opacities, grade 2: 1/3 to 2/3 alveolar opacities, and grade 3: > 2/3 alveolar opacities (Fig. 1).
Fig. 1

Visual representation of the grading system for the chest radiographs, in which a grade 0 assigned for normal, b grade 1 assigned for alveolar opacities < 1/3 of lung, c grade 2 assigned for alveolar opacities 1/3 to 2/3 of lung, and d grade 3 assigned for alveolar opacities > 2/3 of lung

Visual representation of the grading system for the chest radiographs, in which a grade 0 assigned for normal, b grade 1 assigned for alveolar opacities < 1/3 of lung, c grade 2 assigned for alveolar opacities 1/3 to 2/3 of lung, and d grade 3 assigned for alveolar opacities > 2/3 of lung Cox proportional hazards models (for time to event data), proportional odds models (for ordinal categorical data), and logistic regression models (for binary data) were used for association analysis. p values < 0.05 were considered statistically significant. Statistical analysis was performed using R (version 3.6.2, R Core Team, Vienna, Austria).

Results

One thousand two hundred fifty-six patients presented to the CUIMC ED with complaint of fever, cough, shortness of breath, or hypoxia and had a chest X-ray between 12 March 2020 and 26 March 2020. From this, a random sample of 416 patients made up the study population. Six patients were excluded because they had another reason for shortness of breath, cough or fever which was not related to COVID-19 infection. Three patients had prior history of pulmonary disease, such as interstitial lung disease, bronchiectasis, and scarring that would have confounded the grading for alveolar opacities. Two patients had pulmonary edema from cardiac issues, such as acute on chronic congestive heart failure or aortic insufficiency. One patient presented due to physical assault and clinically had no concerns regarding potential COVID-19 infection. No other patients were excluded and there were no self-discharges from the ED. The final cohort consisted of 410 initial chest X-rays. The average age was 59. 50% of patients were female. The average initial oxygen saturation was 96%; of note, most were measured on room air or at patient’s baseline. 25% had diabetes and 50% had hypertension. 55% were not tested for COVID-19 with a PCR exam. Of those who were tested, 69% were positive. Overall, 32 patients were intubated on average of 3.8 days after hospital admission. Twenty patients died, on average 7.8 days after admission. Fifty-nine percent of patients were discharged from the ED. Twenty-five patients remained hospitalized at the time of this manuscript with an average of 19 days since admission. Demographics and clinical outcomes of patients who presented to the ED are divided based on the initial chest X-ray grading in Table 1.
Table 1

Patient demographics and outcomes based on initial chest X-ray findings of patients suspected of having COVID-19 infection

Grade 0aGrade 1bGrade 2cGrade 3d
# of patients226/410 (55%)140/410 (34%)34/410 (8%)10/410 (2%)
Average age55636372
Gender (% female)112/226 (50%)64/140 (46%)20/34 (59%)8/10 (80%)
SARS-CoV-2 positive36/226 (16%)61/140 (44%)24/34 (71%)7/10 (70%)
Not tested for SARS-CoV-2167/226 (74%)52/140 (37%)4/34 (12%)1/10 (10%)
Average initial % O2 saturation97969592
Hypertension100/226 (44%)76/140 (54%)22/34 (65%)7/10 (70%)
Diabetes43/226 (19%)45/140 (32%)12/34 (35%)2/10 (20%)
Discharged from ED172/226 (76%)64/140 (46%)4/34 (12%)0/10 (0%)
Intubated2/226 (<1%)15/140 (11%)10/34 (29%)5/10 (50%)
Hospitalization > 10 days3/226 (1%)12/140 (9%)8/34 (24%)5/10 (50%)
Death2/226 (<1%)9/140 (6%)6/34 (18%)3/10 (30%)

aGrade 0: normal chest X-ray

bGrade 1: < 1/3 alveolar opacities on chest X-ray

cGrade 2: 1/3–2/3 alveolar opacities on chest X-ray

dGrade 3: > 2/3 alveolar opacities on chest X-ray

Patient demographics and outcomes based on initial chest X-ray findings of patients suspected of having COVID-19 infection aGrade 0: normal chest X-ray bGrade 1: < 1/3 alveolar opacities on chest X-ray cGrade 2: 1/3–2/3 alveolar opacities on chest X-ray dGrade 3: > 2/3 alveolar opacities on chest X-ray Excluding the patients who died, 390 surviving patients were analyzed. Oxygen saturation and X-ray grade are both significantly associated with the length of stay in hospital. The HR of discharge is 1.05 (95% CI [1.01, 1.09], p = 0.017) with one unit increase in O2 saturation, and 0.61 (95% CI [0.51, 0.73], p < 0.001) with one grade higher for X-ray (Table 2). Oxygen saturation and X-ray grade were significant predictors of intubation. The odds ratio (OR) of intubation was 0.88 (95% CI [0.81, 0.96], p = 0.004) with one unit increase in O2 saturation, and 3.69 (95% CI [2.25, 6.07], p < 0.001) with one grade higher for X-ray (Table 3).
Table 2

Factors associated with time to discharge from hospital

Hazard ratio95% CIp value
Age0.99460.9871–1.00230.1672
Gender (male)1.02500.8268–1.27070.8219
Oxygen saturation1.05091.0089–1.09460.0170
Diabetes1.08700.8297–1.42410.5448
Hypertension0.90860.7114–1.16050.4426
Chest X-ray grade0.61250.5134–0.7307< 0.001
Table 3

Factors associated with likelihood of intubation

Odds ratio95% CIp value
Age1.00630.9765–1.03710.6809
Gender (male)1.22380.5176–2.89330.6455
Oxygen saturation0.88100.8087–0.95980.0037
Diabetes1.40630.5648–3.50230.4640
Hypertension1.10790.4195–2.92560.8362
Chest X-ray grade3.69272.2459–6.0715< 0.001
Factors associated with time to discharge from hospital Factors associated with likelihood of intubation The hazard ratio (HR) of death with one-year increase in age is 1.095 (95% confidence interval [1.041, 1.152], p = 0.0004) (Table 4). Figure 2 is Kaplan-Meier curve for time to death for 410 patients.
Table 4

Factors associated with increased likelihood of death

Hazard ratio95% CIp value
Age1.09501.0409–1.15200.0004
Gender (male)0.70170.2668–1.84510.4726
Oxygen saturation1.00800.8970–1.13270.8935
Diabetes1.32630.5163–3.41240.5567
Hypertension5.02630.6471–39.04080.1226
Chest X-ray grade1.45340.8328–2.53650.1882
Fig. 2

Overall survival curve for 410 patients

Factors associated with increased likelihood of death Overall survival curve for 410 patients

Discussion

Chest X-rays were performed on all ED patients as part of triaging those who were most in need of hospitalization. Regardless of chest X-ray result, all patients were counseled to isolate themselves from others to slow the spread of infection and dampen the curve with the hope of decreasing hospitalizations and need for ventilators [6, 7]. The majority of patients (55%) who presented to ED with symptoms suspicious for COVID-19 infection had a normal chest X-ray. They were on average younger than those who had consolidations on chest X-ray. The majority of these patients (74%) were not tested for SARS-CoV-2 and had higher average initial oxygen saturation compared to those that tested positive. There were fewer patients with diabetes and hypertension in this subgroup; diabetes and hypertension have been associated with worse outcomes for patients with COVID-19 infection [8, 9]. The majority of these patients (76%) were discharged from the ED, with only 1% having a prolonged hospital stay of 10 days or greater. Less than 1% died or were intubated. However, 24% of patients with a normal chest radiograph initially was not discharged from the ED and was admitted for further treatment. A normal chest radiograph alone cannot be used for triage of COVID-19, as mild or early disease may not be reflected radiographically, as radiographic findings may lag behind clinical presentation. In contrast, those who had findings of alveolar opacities on chest X-ray were older than those without alveolar opacities. Increasing severity of alveolar opacities on chest X-ray was associated with increasing age. Surprisingly, the percentage of females was higher in the group with the highest chest X-ray grade. Previous reports had described a worse prognosis for men, which were explained by greater likelihood of smoking [10, 11]. This group of patients was more likely to have a PCR test and to test positive. As would be expected, their oxygen saturations were lower proportional to the amount of disease. The majority of the patients in this group had hypertension and diabetes, which has been reported [8, 9]. These patients had worse outcomes overall and proportionate to the amount of consolidation. Fewer could be discharged from emergency room and a greater percentage required intubation and ultimately died. Not surprisingly, lower oxygen saturation and higher degree of alveolar opacities on the initial chest X-ray regardless of COVID-19 result were associated with increased duration of hospitalization and increased likelihood of intubation. The Fleischner Society published a multinational consensus statement on 7 April 2020 regarding the use of chest imaging during the COVID-19 pandemic, which was published after the data collection period for this paper, and presented three different scenarios and algorithm for recommendation on the use of chest imaging. Essentially, the early period of the COVID-19 pandemic in New York City mirrored the third scenario depicted in the consensus statement, which was the lack of availability of COVID-19 testing. The consesus statement reiterated the importance of imaging to quickly triage patients when presented with high influx of new patients [12]. Limitations include a retrospective, single center study with a single radiologist interpreting the radiographs to a novel grading system tailored to the current pandemic within the United States. Future studies should include more readers to compare performance and can be extended to include multiple institutions treating a large number of patients with COVID-19. Many patients remain hospitalized in critical condition and on mechanical ventilation; the data presented in this manuscript are related to the current state of our institution during the pandemic and are subject to change as patients recover or pass away.

Conclusion

In conclusion, a normal chest X-ray does not exclude the diagnosis of COVID-19, but can serve as a useful diagnostic tool for evaluation and appropriate triage of patients with suspected COVID-19 infection, particularly at a time when hospital beds are limited, demand is high, and the disease begins to affect different regions of the country that may not have suitable inpatient and ICU bed capacity. Patients with near total or complete involvement of the lungs are at higher risk for poor clinical outcome with higher rates of intubation and extended hospitalization.

Code availability

Not applicable.
  27 in total

1.  ThoraciNet: thoracic abnormality detection and disease classification using fusion DCNNs.

Authors:  Manav Gakhar; Apeksha Aggarwal
Journal:  Phys Eng Sci Med       Date:  2022-05-30

Review 2.  Multiorgan Involvement in SARS-CoV-2 Infection: The Role of the Radiologist from Head to Toe.

Authors:  Davide Ippolito; Federica Vernuccio; Cesare Maino; Roberto Cannella; Teresa Giandola; Maria Ragusi; Vittorio Bigiogera; Carlo Capodaglio; Sandro Sironi
Journal:  Diagnostics (Basel)       Date:  2022-05-10

3.  Usefulness of Hospital Admission Chest X-ray Score for Predicting Mortality and ICU Admission in COVID-19 Patients.

Authors:  Trieu-Nghi Hoang-Thi; Duc-Tuan Tran; Hai-Dang Tran; Manh-Cuong Tran; Tra-My Ton-Nu; Hong-Minh Trinh-Le; Hanh-Nhi Le-Huu; Nga-My Le-Thi; Cong-Trinh Tran; Nhat-Nam Le-Dong; Anh-Tuan Dinh-Xuan
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

4.  Development and Validation of a Multimodal-Based Prognosis and Intervention Prediction Model for COVID-19 Patients in a Multicenter Cohort.

Authors:  Jeong Hoon Lee; Jong Seok Ahn; Myung Jin Chung; Yeon Joo Jeong; Jin Hwan Kim; Jae Kwang Lim; Jin Young Kim; Young Jae Kim; Jong Eun Lee; Eun Young Kim
Journal:  Sensors (Basel)       Date:  2022-07-02       Impact factor: 3.847

Review 5.  COVID-19 pneumonia-ultrasound, radiographic, and computed tomography findings: a comprehensive pictorial essay.

Authors:  Michaela Cellina; Carlo Martinenghi; Pietro Marino; Giancarlo Oliva
Journal:  Emerg Radiol       Date:  2021-01-30

6.  Predicting Prolonged Hospitalization and Supplemental Oxygenation in Patients with COVID-19 Infection from Ambulatory Chest Radiographs using Deep Learning.

Authors:  Ayis Pyrros; Adam Eugene Flanders; Jorge Mario Rodríguez-Fernández; Andrew Chen; Patrick Cole; Daniel Wenzke; Eric Hart; Samuel Harford; Jeanne Horowitz; Paul Nikolaidis; Nadir Muzaffar; Viveka Boddipalli; Jai Nebhrajani; Nasir Siddiqui; Melinda Willis; Houshang Darabi; Oluwasanmi Koyejo; William Galanter
Journal:  Acad Radiol       Date:  2021-05-21       Impact factor: 3.173

7.  Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score.

Authors:  Luke Tseng; Erin Hittesdorf; Mitchell F Berman; Desmond A Jordan; Nina Yoh; Katerina Elisman; Katherine A Eiseman; Yuqi Miao; Shuang Wang; Gebhard Wagener
Journal:  Crit Care Res Pract       Date:  2021-05-31

Review 8.  COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development.

Authors:  Joowon Yim; Hee Hyun Lim; Youngjoo Kwon
Journal:  Arch Pharm Res       Date:  2021-05-28       Impact factor: 6.010

9.  Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.

Authors:  Abiu Sempere-González; Jordi Llaneras-Artigues; Iago Pinal-Fernández; Esperanza Cañas-Ruano; Olimpia Orozco-Gálvez; Eva Domingo-Baldrich; Xabier Michelena; Beatriz Meza; Eloi García-Vives; Albert Gil-Vila; Javier Sarrapio-Lorenzo; Sheila Romero-Ruperto; Francesc Sanpedro-Jiménez; María Arranz-Betegón; Andreu Fernández-Codina
Journal:  Med Clin (Barc)       Date:  2021-06-16       Impact factor: 3.200

10.  Diagnosis of Coronavirus Disease 2019 Pneumonia by Using Chest Radiography: Value of Artificial Intelligence.

Authors:  Ran Zhang; Xin Tie; Zhihua Qi; Nicholas B Bevins; Chengzhu Zhang; Dalton Griner; Thomas K Song; Jeffrey D Nadig; Mark L Schiebler; John W Garrett; Ke Li; Scott B Reeder; Guang-Hong Chen
Journal:  Radiology       Date:  2020-09-24       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.